Biopsy Devices Market by Product (Core Needle Biopsy, Aspiration Biopsy, Vacuum Assisted Biopsy) Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy) Guidance (Stereotactic, Ultrasound) & by End User (Hospital) - Global Forecast to 2028
Inquire Now to get the Global Forecasts Data upto 2028
[222 Pages Report] The global biopsy devices market is projected to reach USD 2.42 Billion by 2022 from USD 1.63 Billion in 2016, at a CAGR of 6.8% from 2017 to 2022. The growth in this market is primarily attributed to the rising prevalence of cancer, increasing demand for minimally invasive surgeries, initiatives undertaken by government & global health organizations to spread awareness about cancer, and the improved reimbursement scenario in the U.S.
Years Considered for this Report
- 2016 – Base Year
- 2017 – Estimated Year
- 2022 – Projected Year
Objectives of the Study
- To define, describe, and forecast the global biopsy devices market on the basis of product, guidance technique, application, end user, and region.
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, challenges, and trends)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players
- To forecast the size of the market, in five main regions,namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa
- To profile key players in the global market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as expansions, partnerships, and alliances; mergers and acquisitions; new product/technology developments; and research and development activities of the leading players in the market
Research Methodology
Top-down and bottom-up approaches were used to validate the size of the global biopsy devices market and estimate the size of various other dependent submarkets. Major players in the market were identified through secondary research and their market revenues were determined through primary and secondary research. Secondary research included the study of the annual and financial reports of top market players, whereas primary research included extensive interviews with the key opinion leaders such as CEOs, directors, and marketing executives. The percentage splits, shares, and breakdowns of the product markets were determined using secondary sources and verified through primary sources. This data is consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report. Some of the secondary resources we referred are U.S. Food and Drug Administration, Centers for Disease Control and Prevention, Occupational Safety and Health Administration, and World Bank.
To know about the assumptions considered for the study, download the pdf brochure
The global biopsy devices market ecosystem comprises of the following players, namely, C. R. Bard, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (U.S.), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (U.S.), Olympus Corporation (Japan), Boston Scientific Corporation (U.S.), FUJIFILM Holdings Corporation (Japan), INRAD, Inc. (U.S.), and Medtronic plc (Ireland).
Target Audience:
- Biopsy Device Manufacturers
- Suppliers and Distributors of Biopsy Devices
- Research Institutes and Academic Centers
- Hospitals
- Oncology Centers
- Health Insurance Payers
- Regulatory Authorities
- Venture Capitalists
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Request Sample Scope of the Report
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
The research report categorizes the global market into the following segments and subsegments:
Global Biopsy Devices Market, by Product
-
Needle-based Biopsy Instruments
-
Core Biopsy Devices
- Core Biopsy Guns
- Core Biopsy Needles
- Aspiration Biopsy Needles
-
Vacuum-assisted Biopsy Devices
- Vacuum-assisted Biopsy Systems
- Vacuum-assisted Biopsy Needles
-
Core Biopsy Devices
- Localization Wires
- Procedure Trays
- Others
Global Biopsy Devices Market, by Guidance Technique
- Ultrasound-guided Biopsy
- Stereotactic-guided Biopsy
- MRI-guided Biopsy
- Others
Global Biopsy Devices Market, by Application
- Breast Biopsy
- Lung Biopsy
- Colorectal Biopsy
- Prostate Biopsy
- Others
Global Biopsy Devices Market, by End User
- Hospitals
- Academic and Research Institutes
- Diagnostic and Imaging Centers
Global Biopsy Devices Market, by Region
-
North America
- U.S.
- Canada
-
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
-
Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- Latin America
- Middle East and Africa
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Geographic Analysis
- Further breakdown of the Rest of Asia-Pacific biopsy devices market into South Korea, Australia, New Zealand, and others
- Further breakdown of the Rest of Europe biopsy devices market into Belgium, Russia, the Netherlands, Switzerland, and others
- Further breakdown of Latin America market into Brazil, Mexico, and others
Company Information
- Detailed analysis and profiling of additional market players (Up to 5)
The global biopsy devices market is projected to reach USD 2.42 Billion by 2022 from USD 1.74 Billion in 2017, growing at a CAGR of 6.8% during the forecast period. Factors such as increasing cancer prevalence, the shift towards minimally invasive surgeries, growing government & global health organizations initiatives to spread awareness about cancer, and the improved reimbursement scenario in U.S. are boosting the growth of global market.
The report analyzes the global biopsy devices market by product, guidance technique, application, end user, and region. Based on product, the global market is segmented into needle-based biopsy instruments, procedure trays, localization wires, and other products (forceps, markers, probes, punches, curettes, and sutures). In 2016, the needle-based biopsy instruments segment accounted for the largest share of global market mainly due to the increasing preference for minimally invasive surgeries and higher preference for needle-based biopsies over open surgical biopsies.
Based on application, the global market is segmented into breast biopsy, lung biopsy, colorectal biopsy, prostate biopsy, and others. The breast biopsy segment accounted for the largest share of the global market in 2016. The rising prevalence of breast cancer and growing awareness about the disease are driving market growth in this segment.
On the basis of guidance technique, the biopsy devices market is segmented into ultrasound-guided biopsy, stereotactic-guided biopsy, magnetic resonance imaging (MRI)-guided biopsy, and other guidance techniques (positron emission tomography, fluoroscopy, and thermography). In 2016, the ultrasound biopsy segment dominated the market.
Based on end user, the market is segmented into hospitals, diagnostic & imaging centers, and academic & research institutes. In 2016, hospitals formed the largest end-user segment of the market. This can be attributed to the growth in the healthcare sector in emerging economies along with the increase in the out-of-pocket healthcare expenditure and increase in the number of hospitals.
Geographically, the global biopsy devices market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America holds the largest share of this market. However, the Asia-Pacific region is expected to witness the highest CAGR during the forecast period of 2017 to 2022. The growth of this segment can be attributed to the rising prevalence of cancer, large population in countries such as China and India, improving healthcare infrastructure, increasing healthcare spending and government initiatives, and rising focus of key market players in the region are driving the growth of market in Asia-Pacific.
However, patient safety risks associated with biopsy devices leading to product recalls and risk of infections related to biopsy procedures are expected to hinder the growth of this market to a certain extent.
The global biopsy devices market is characterized by a large number of players. The market is highly competitive in nature and is dominated by C. R. Bard, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (U.S.), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (U.S.), Olympus Corporation (Japan), Boston Scientific Corporation (U.S.), FUJIFILM Holdings Corporation (Japan), INRAD, Inc. (U.S.), and Medtronic plc (Ireland). Key players in the market are pursuing several organic and inorganic growth strategies such as product launches, expansions, acquisitions, and agreements to garner larger shares of the market. During 2013 to 2017, companies adopted product launches as their major growth strategy followed by acquisitions
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction (Page No. - 19)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. - 22)
2.1 Research Approach
2.1.1 Secondary Sources
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Sources
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study
3 Executive Summary (Page No. - 30)
4 Premium Insights (Page No. - 35)
4.1 Biopsy Devices: Market Overview
4.2 Biopsy Devices Market: Developed vs Developnig Countries
4.3 Geographic Snapshot: Biopsy Devices Market (2016)
4.4 Market, By Product (2017 vs 2022)
4.5 Market : Geographic Mix
5 Market Overview (Page No. - 39)
5.1 Key Market Dynamics
5.1.1 Market Drivers
5.1.1.1 Rising Prevalence of Cancer
5.1.1.2 Increasing Preference for Minimally Invasive Surgeries
5.1.1.3 Initiatives Undertaken By Government and Global Health Organizations
5.1.1.4 Improved Reimbursement Scenario in U.S.
5.1.2 Market Restraints
5.1.2.1 Product Recalls
5.1.2.2 Risk of Infections
5.1.3 Market Opportunities
5.1.3.1 Emerging Economies
5.1.4 Market Challenges
5.1.4.1 Underdeveloped Healthcare Infrastructure and Dearth of Resources in Developing Countries
5.2 Industry Trends
5.2.1 Emergence of Liquid Biopsy
5.2.2 Development of Fully Integrated Biopsy Devices
5.3 Regulatory Analysis
5.3.1 North America
5.3.1.1 U.S.
5.3.2 Europe
5.3.3 APAC
5.3.3.1 Japan
5.3.3.2 China
5.3.3.3 India
5.3.4 Latin America
5.3.4.1 Brazil
5.3.4.2 Mexico
5.3.4.3 Colombia
6 Global Biopsy Devices Market, By Product (Page No. - 58)
6.1 Introduction
6.2 Needle-Based Biopsy Instruments
6.2.1 Core Biopsy Devices
6.2.2 Aspiration Biopsy Needles
6.2.3 Vacuum-Assisted Biopsy Devices
6.3 Procedure Trays
6.4 Localization Wires
6.5 Other Products
7 Global Biopsy Devices Market, By Application (Page No. - 72)
7.1 Introduction
7.2 Breast Biopsy
7.3 Lung Biopsy
7.4 Colorectal Biopsy
7.5 Prostate Biopsy
7.6 Other Applications
8 Global Biopsy Devices Market, By Guidance Technique (Page No. - 81)
8.1 Introduction
8.2 Ultrasound-Guided Biopsy
8.3 Stereotactic-Guided Biopsy
8.4 Mri-Guided Biopsy
8.5 Other Guidance Techniques
9 Global Biopsy Devices Market, By End User (Page No. - 87)
9.1 Introduction
9.2 Hospitals
9.3 Academic and Research Institutes
9.4 Diagnostic and Imaging Centers
10 Biopsy Devices Market, By Region (Page No. - 93)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 U.K.
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia-Pacific
10.5 Latin America
10.6 Middle East and Africa
11 Competitive Landscape (Page No. - 164)
11.1 Introduction
11.2 Market Share Analysis
11.3 Competitive Leadership Mapping
11.3.1 Visionary Leaders
11.3.2 Innovators
11.3.3 Emerging Companies
11.3.4 Dynamic Differentiators
11.4 Competitive Benchmarking
11.4.1 Strength of Product Portfolio (26 Players)
11.4.2 Business Strategyexcellence (26 Players)
*Top 25 Companies Analysed for This Study are - C. R. Bard, Inc. (U.S.), Cook Group Incorporated (U.S.), Becton, Dickinson and Company (U.S.), Devicor Medical Products, Inc. (Leica) (U.S.), Argon Medical Devices, Inc. (U.S.), Inrad Inc. (U.S.), Somatex Medical Technologies GmbH (Germany), Tsunami S.R.L. (Italy), Scion Medical Technologies, LLC (U.S.), Uromed Kurt Drews Kg (U.S.), Sterylab S.R.L. (Italy), Dtr Medical Ltd (U.K.), Endomed Systems GmbH (Germany), Conmed Corporation (U.S.), Tsk Laboratory Europe B.V. (Netherlands), Zamar Care (Croatia), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (U.S.), Siemens Healthineers (Germany), Ge Healthcare (U.K.), Boston Scientific Corporation (U.S.), Fujifilm Holdings Corporation (U.S.), Olympus Corporation (Japan), Gallini S.R.L. (Italy), Medtronic PLC (Ireland)
12 Company Profiles (Page No. - 169)
(Overview, Strength of Product Portfolio Business Strategy Excellence Products Offering, Recent Development’s, Business Strategy)*
12.1 C. R. Bard, Inc.
12.2 Becton, Dickinson and Company
12.3 Cook Group Incorporated
12.4 Devicor Medical Products, Inc. (A Part of Leica Biosystems)
12.5 Argon Medical Devices, Inc.
12.6 B. Braun Melsungen AG
12.7 Cardinal Health, Inc.
12.8 Olympus Corporation
12.9 Boston Scientific Corporation
12.10 Fujifilm Holdings Corporation
12.11 Inrad, Inc.
12.12 Medtronic PLC
12.13 Hologic, INC.
*Details on Overview, Strength of Product Portfolio Business Strategy Excellence Products Offering, Recent Development’s, Business Strategy might not be capturedMight Not Be Captured in caseCase of unlisted companiesUnlisted Companies.
13 Appendix (Page No. - 212)
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.3 Introducing RT: Real-Time Market Intelligence
13.4 Available Customizations
13.5 Related Reports
13.6 Author Details
List of Tables (180 Tables)
Table 1 Comparison of Reimbursement for Biopsy Procedures, 2015 vs 2017
Table 2 Reimbursement for Biopsy Procedures, 2017
Table 3 Indicative List of FDA Product Recalls for Biopsy Devices (2016–2017)
Table 4 Biopsy Devices Under 21 Cfr 876.1075 With Product Codes
Table 5 Classification of Medical Devices and the Reviewing Body in Japan
Table 6 Nomenclature of Applicable Medical Devices With Codes
Table 7 Regulatory Classification for Medical Devices in India
Table 8 Brazil: Time, Cost, and Complexity of the Registration Process
Table 9 Mexico: Time, Cost, and Complexity of Registration Process
Table 10 Colombia: Time, Cost, and Complexity of Registration Process
Table 11 Global Market, By Product, 2015–2022 (USD Million)
Table 12 Global Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 13 Global Needle-Based Biopsy Instruments Market, By Country/Region, 2015–2022 (USD Million)
Table 14 Major Brands of Core Biopsy Devices
Table 15 Global Core Market, By Country/Region, 2015–2022 (USD Million)
Table 16 Global Core Market, By Product, 2015–2022 (USD Million)
Table 17 Global Core Biopsy Guns Market, By Country/Region, 2015–2022 (USD Million)
Table 18 Global Core Biopsy Needles Market, By Country/Region, 2015–2022 (USD Million)
Table 19 Major Brands of Aspiration Biopsy Needles
Table 20 Global Aspiration Biopsy Needles Market, By Country/Region, 2015–2022 (USD Million)
Table 21 Major Brands of Vacuum-Assisted Biopsy Devices
Table 22 Global Vacuum-Assisted Market, Region/Country, 2015–2022 (USD Million)
Table 23 Global Vacuum-Assisted Market, By Product, 2015–2022 (USD Million)
Table 24 Global Vacuum-Assisted Biopsy Systems Market, By Country/Region, 2015–2022 (USD Million)
Table 25 Global Vacuum-Assisted Biopsy Needles Market, By Country/Region, 2015–2022 (USD Million)
Table 26 Global Procedure Trays Market, By Country/Region, 2015–2022 (USD Million)
Table 27 Major Brands of Localization Wires
Table 28 Global Localization Wires Market Size, By Country/Region, 2015–2022 (USD Million)
Table 29 Global Other Biopsy Products Market, By Country/Region, 2015–2022 (USD Million)
Table 30 Global Market, By Application, 2015–2022 (USD Million)
Table 31 Global Market for Breast Biopsy, By Country/Region, 2015–2022 (USD Million)
Table 32 Global Market for Lung Biopsy, By Country/Region, 2015–2022 (USD Million)
Table 33 Global Market for Colorectal Biopsy, By Country/Region, 2015–2022 (USD Million)
Table 34 Global Market for Prostate Biopsy, By Country/Region, 2015–2022 (USD Million)
Table 35 Global Market for Other Applications, By Country/Region, 2015–2022 (USD Million)
Table 36 Global Market, By Guidance Technique, 2015–2022 (USD Million)
Table 37 Global Market for Ultrasound-Guided Biopsy, By Country/Region, 2015–2022 (USD Million)
Table 38 Global Market for Stereotactic-Guided Biopsy, By Country/Region, 2015–2022 (USD Million)
Table 39 Global Market for Mri-Guided Biopsy, By Country/Region, 2015–2022 (USD Million)
Table 40 Global Market for Other Guidance Techniques, By Country/Region, 2015–2022 (USD Million)
Table 41 Global Biopsy Devices Market, By End User, 2015–2022 (USD Million)
Table 42 Number of Hospitals, By Region (2010 vs 2014)
Table 43 Global Market for Hospitals, By Country/Region, 2015–2022 (USD Million)
Table 44 Global Market for Academic and Research Institutes, By Country/Region, 2015–2022 (USD Million)
Table 45 Global Market for Diagnostic and Imaging Centers, By Country/Region, 2015–2022 (USD Million)
Table 46 Market, By Region, 2015–2022 (USD Million)
Table 47 North America: Market, By Country, 2015–2022 (USD Million)
Table 48 North America: Market, By Product, 2015–2022 (USD Million)
Table 49 North America: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 50 North America: Core Market, By Type, 2015–2022 (USD Million)
Table 51 North America: Vacuum-Assisted Market, By Type, 2015–2022 (USD Million)
Table 52 North America: Market, By Application, 2015–2022 (USD Million)
Table 53 North America: Market, By Guiding Technique, 2015–2022 (USD Million)
Table 54 North America: Market, By End User, 2015–2022 (USD Million)
Table 55 Estimated New Cases of Cancer in 2017
Table 56 Key Market Indicators: U.S.
Table 57 U.S.: Market, By Product, 2015–2022 (USD Million)
Table 58 U.S.: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 59 U.S.: Core Market, By Type, 2015–2022 (USD Million)
Table 60 U.S.: Vacuum-Assisted Biopsy Device Market, By Type, 2015–2022 (USD Million)
Table 61 U.S.: Market, By Application, 2015–2022 (USD Million)
Table 62 U.S.: Market, By Guidance Technique, 2015–2022 (USD Million)
Table 63 U.S.: Market, By End User, 2015–2022 (USD Million)
Table 64 Key Market Indicators: Canada
Table 65 Overview of the Breast, Cervical, and Colorectal Cancer Screening Programs Across Canada
Table 66 Canada: Market, By Product, 2015–2022 (USD Million)
Table 67 Canada: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 68 Canada: Core Market, By Type, 2015–2022 (USD Million)
Table 69 Canada: Vacuum-Assisted Market, By Type, 2015–2022 (USD Million)
Table 70 Canada: Market, By Application, 2015–2022 (USD Million)
Table 71 Canada: Market, By Guidance Technique, 2015–2022 (USD Million)
Table 72 Canada: Market, By End User, 2015–2022 (USD Million)
Table 73 Europe: Market, By Country 2015–2022 (USD Million)
Table 74 Europe: Market, By Product, 2015–2022 (USD Million)
Table 75 Europe: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 76 Europe: Core Biopsy Device Market, By Type, 2015–2022 (USD Million)
Table 77 Europe: Vacuum-Assisted Biopsy Device Market, By Type, 2015–2022 (USD Million)
Table 78 Europe: Market, By Application, 2015–2022 (USD Million)
Table 79 Europe: Market, By Guidance Technique, 2015–2022 (USD Million)
Table 80 Europe: Market, By End User, 2015–2022 (USD Million)
Table 81 Key Market Indicators: Germany
Table 82 Germany: Market, By Product, 2015–2022 (USD Million)
Table 83 Germany: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 84 Germany: Core Biopsy Device Market, By Type, 2015–2022 (USD Million)
Table 85 Germany: Vacuum-Assisted Biopsy Device Market, By Type, 2015–2022 (USD Million)
Table 86 Germany: Market, By Application, 2015–2022 (USD Million)
Table 87 Germany: Market, By Guidance Technique, 2015–2022 (USD Million)
Table 88 Germany: Market, By End User, 2015–2022 (USD Million)
Table 89 Key Market Indicators: France
Table 90 France: Market, By Product, 2015–2022 (USD Million)
Table 91 France: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 92 France: Core Biopsy Device Market, By Type, 2015–2022 (USD Million)
Table 93 France: Vacuum-Assisted Biopsy Device Market, By Type, 2015–2022 (USD Million)
Table 94 France: Market, By Application, 2015–2022 (USD Million)
Table 95 France: Market, By Guidance Technique, 2015–2022 (USD Million)
Table 96 France: Market, By End User, 2015–2022 (USD Million)
Table 97 Key Market Indicators: U.K.
Table 98 U.K.: Market, By Product, 2015–2022 (USD Million)
Table 99 U.K.: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 100 U.K.: Core Biopsy Device Market, By Type, 2015–2022 (USD Million)
Table 101 U.K.: Vacuum-Assisted Biopsy Device Market, By Type, 2015–2022 (USD Million)
Table 102 U.K.: Market, By Application, 2015–2022 (USD Million)
Table 103 U.K.: Market, By Guidance Technique, 2015–2022 (USD Million)
Table 104 U.K.: Market, By End User, 2015–2022 (USD Million)
Table 105 Key Market Indicators: Italy
Table 106 Italy: Market, By Product, 2015–2022 (USD Million)
Table 107 Italy: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 108 Italy: Core Biopsy Device Market, By Type, 2015–2022 (USD Million)
Table 109 Italy: Vacuum-Assisted Biopsy Device Market, By Type, 2015–2022 (USD Million)
Table 110 Italy: Market, By Application, 2015–2022 (USD Million)
Table 111 Italy: Market, By Guidance Technique, 2015–2022 (USD Million)
Table 112 Italy: Market, By End User, 2015–2022 (USD Million)
Table 113 Key Market Indicators: Spain
Table 114 Spain: Market, By Product, 2015–2022 (USD Million)
Table 115 Spain: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 116 Spain: Core Biopsy Device Market, By Type, 2015–2022 (USD Million)
Table 117 Spain: Vacuum-Assisted Biopsy Device Market, By Type, 2015–2022 (USD Million)
Table 118 Spain: Market, By Application, 2015–2022 (USD Million)
Table 119 Spain: Market, By Guidance Technique, 2015–2022 (USD Million)
Table 120 Spain: Market, By End User, 2015–2022 (USD Million)
Table 121 RoE: Market, By Product, 2015–2022 (USD Million)
Table 122 RoE: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 123 RoE: Core Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 124 RoE: Vacuum-Assisted Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 125 RoE: Market, By Application, 2015–2022 (USD Million)
Table 126 RoE: Market, By Guidance Technique, 2015–2022 (USD Million)
Table 127 RoE: Market, By End User, 2015–2022 (USD Million)
Table 128 APAC: Biopsy Devices Market, By Country, 2015–2022 (USD Million)
Table 129 APAC: Market, By Product, 2015–2022 (USD Million)
Table 130 APAC: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 131 APAC: Core Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 132 APAC: Vacuum-Assisted Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 133 APAC: Market, By Application, 2015–2022 (USD Million)
Table 134 APAC: Market, By Guidance Technique, 2015–2022 (USD Million)
Table 135 APAC: Market, By End User, 2015–2022 (USD Million)
Table 136 Key Market Indicators: Japan
Table 137 Japan: Biopsy Devices Market, By Product, 2015–2022 (USD Million)
Table 138 Japan: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 139 Japan: Core Market, By Type, 2015–2022 (USD Million)
Table 140 Japan: Vacuum-Assisted Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 141 Japan: Biopsy Devices Market, By Application, 2015–2022 (USD Million)
Table 142 Japan: Market, By Guidance Technique, 2015–2022 (USD Million)
Table 143 Japan: Market, By End User, 2015–2022 (USD Million)
Table 144 Key Market Indicators: China
Table 145 China: Biopsy Devices Market, By Product, 2015–2022 (USD Million)
Table 146 China: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 147 China: Core Market, By Type, 2015–2022 (USD Million)
Table 148 China: Vacuum-Assisted Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 149 China: Market, By Application, 2015–2022 (USD Million)
Table 150 China: Market, By Guidance Technique, 2015–2022 (USD Million)
Table 151 China: Market, By End User, 2015–2022 (USD Million)
Table 152 Key Market Indicators: India
Table 153 India: Biopsy Devices Market, By Product, 2015–2022 (USD Million)
Table 154 India: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 155 India: Core Market, By Type, 2015–2022 (USD Million)
Table 156 India: Vacuum-Assisted Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 157 India: Biopsy Devices Market, By Application, 2015–2022 (USD Million)
Table 158 India: Market, By Guidance Technique, 2015–2022 (USD Million)
Table 159 India: Market, By End User, 2015–2022 (USD Million)
Table 160 RoAPAC: Biopsy Devices Market, By Product, 2015–2022 (USD Million)
Table 161 RoAPAC: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 162 RoAPAC: Core Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 163 RoAPAC: Vacuum-Assisted Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 164 RoAPAC: Market, By Application, 2015–2022 (USD Million)
Table 165 RoAPAC: Market, By Guidance Technique, 2015–2022 (USD Million)
Table 166 RoAPAC: Biopsy Devices Market, By End User, 2015–2022 (USD Million)
Table 167 Latin America: Biopsy Devices Market, By Product, 2015–2022 (USD Million)
Table 168 Latin America: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 169 Latin America: Core Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 170 Latin America: Vacuum-Assisted Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 171 Latin America: Market, By Application, 2015–2022 (USD Million)
Table 172 Latin America: Market, By Guidance Technique, 2015–2022 (USD Million)
Table 173 Latin America: Biopsy Devices Market, By End User, 2015–2022 (USD Million)
Table 174 Middle East and Africa: Biopsy Devices Market, By Product, 2015–2022 (USD Million)
Table 175 Middle East and Africa: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 176 Middle East and Africa: Core Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 177 Middle East and Africa: Vacuum-Assisted Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 178 Middle East and Africa: Market, By Application, 2015–2022 (USD Million)
Table 179 Middle East and Africa: Biopsy Devices Market, By Guidance Technique, 2015–2022 (USD Million)
Table 180 Middle East and Africa: Market, By End User, 2015–2022 (USD Million)
List of Figures (43 Figures)
Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Global Biopsy Market, By Product, 2017 vs 2022 (USD Billion)
Figure 7 Global Biopsy Devices Market, By Application, 2017 vs 2022 (USD Billion)
Figure 8 Global Market, By Guidance Technique, 2017 vs 2022 (USD Billion)
Figure 9 Global Market, By End User, 2017 vs 2022 (USD Billion)
Figure 10 Geographic Snapshot: Biopsy Devices Market
Figure 11 Increasing Prevalence of Cancer is the Key Market Driver for Biopsy Devices
Figure 12 Developing Markets to Register Higher Growth During the Forecast Period
Figure 13 U.S. Accounted for the Largest Share of the Biopsy Devices Market in 2016
Figure 14 Needle-Based Biopsy Instruments Will Continue to Dominate the Biopsy Devices Market in 2022
Figure 15 North America to Dominate the Global Biopsy Devices Market During the Forecast Period
Figure 16 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 Cancer Prevalence and Mortality Rate, By Country, 2012
Figure 18 Increasing Cancer Prevalence in the Geriatric Population (2012–2030)
Figure 19 CE Mark Approval Process for Biopsy Devices in Europe
Figure 20 Regulatory Process for Medical Devices in Brazil
Figure 21 Regulatory Process for Medical Devices in Mexico
Figure 22 Regulatory Process for Medical Devices in Colombia
Figure 23 Global Market, By Product, 2017 vs 2022 (USD Million)
Figure 24 Breast Biopsy to Dominate the Biopsy Devices Market in 2017
Figure 25 Ultrasound-Guided Biopsy to Dominate the Biopsy Devices Market During the Forecast Period
Figure 26 Hospitals Will Continue to Dominate the Biopsy Devices Market in 2022
Figure 27 Biopsy Devices Market: Geographic Growth Opportunities
Figure 28 North America: Biopsy Devices Market Snapshot
Figure 29 Canada: Cancer Statistics
Figure 30 Europe: Market Snapshot
Figure 31 APAC: Biopsy Devices Market Snapshot
Figure 32 Global Market Share Analysis, By Key Player, 2016
Figure 33 Biopsy Devices Market (Global), Competitive Leadership Mapping, 2017
Figure 34 C.R. Bard, Inc.: Company Snapshot
Figure 35 Becton, Dickinson and Company: Company Snapshot
Figure 36 Danaher Corporation: Company Snapshot
Figure 37 B. Braun Melsungen AG: Company Snapshot
Figure 38 Cardinal Health, Inc.: Company Snapshot
Figure 39 Olympus Corporation: Company Snapshot
Figure 40 Boston Scientific Corporation: Company Snapshot
Figure 41 Fujifilm Holdings Corporation: Company Snapshot
Figure 42 Medtronic PLC: Company Snapshot
Figure 43 Hologic, Inc.: Company Snapshot
Generating Response ...
Growth opportunities and latent adjacency in Biopsy Devices Market